Capabilities
Get The Research
Wall Street Can't Provide
Underwriters don't publish research for 30 days after pricing.
Why the World's Top Investment Firms Rely on IPO Intelligence
Every IPO forces a decision on a compressed timeline with limited independent research.
Get unbiased, actionable opinions on every deal based on in-depth valuation analysis while it still matters. Not after the 30-day blackout. Not from the underwriter. From the only independent IPO research team that's been doing this for over 35 years.
What Your Team Gets on Every IPO
From the moment an IPO is filed to the day it prices, your team has independent research that doesn't exist anywhere else.
Before You See the Roadshow
Your team receives an independent investment opinion, risk assessment, and valuation framework on every IPO — built from our own fundamental analysis, not recycled from the underwriter's pitch book.
Tailored to How You Invest
Filter by market cap, sector, geography, or growth profile. Consult directly with our research analysts. Request custom data sets. The platform adapts to your mandate — not the other way around.
The Difference Is Clear
Discover what your competitors are working with vs. what you could have.
There really isn't a comparison.
Without IPO Intelligence
-
✕Relying on the same underwriter pitch book as every other allocator in the deal.
-
✕No independent research available during the 30-day post-IPO blackout.
-
✕Building valuation models under deadline pressure.
-
✕Making allocation decisions based on incomplete or conflicted information.
With IPO Intelligence®
-
✓Independent ratings and investment opinions before the roadshow ends.
-
✓Full research coverage that doesn’t stop when Wall Street goes silent.
-
✓Dynamic Excel DCF models you can customize in your own workflow.
-
✓Complete lifecycle coverage from pre-filing through pricing and beyond.
Your Team is Covered at Every Stage
Company Watchlist
Spot opportunities before anyone else sees the filing.
IPO Pipeline
Stay ahead of every deal in your mandate.
Profile & Research
Independent analysis that replaces underwriter pitches.
Pricing Insights
Make your final allocation with real-time pricing data.
Four Capabilities Your Team Won't Find Anywhere Else
In-Depth Pre-IPO Research
Within days of an IPO filing, your team has an independent investment opinion covering business fundamentals, shareholder makeup, valuation, and relevant comparables. Not a summary — a real bull-bear case for every deal.
- Real bull and bear case for every deal
- Industry insights and relevant context
- Actionable briefing ready for your investment committee
- In your hands in time to inform allocation decisions
Run Your Own Scenarios — Don't Trust the Underwriter's Numbers
Download editable Excel DCF models built on our independent estimates. Adjust growth assumptions, test valuation sensitivity, and integrate directly with your platform. Your numbers, your analysis, your conviction.
- Integrated comp sheets with live data
- Test the impact of estimate and multiple changes instantly
- Customize peer groups to match your thesis
- Export-ready for your investment platform
See the Full IPO Landscape — Not Just the Next Deal
Your team gets the top-down view that turns individual deals into a market strategy. Detailed calendars, deal flow tracking, market commentary, and sector analysis — everything you need to manage IPO exposure as a portfolio allocation, not a series of one-off decisions.
- Weekly IPO market commentary from the team that's tracked IPOs for over 35 years
- Monthly, quarterly, and annual reviews for your records
- Deal pipeline tracking and trend analysis
- Top-down market insights that inform your allocation strategy
All IPOs Across Every Market, Sector, and Cap Size
Every U.S. IPO. Every major international listing. Every industry and market cap. Each prospective deal flows through our multi-step coverage process with consistent methodology — so your team compares apples to apples across the entire market.
- All U.S. and major international IPOs covered
- Every industry, sector, and market cap
- Independently assigned investability ratings
- Consistent research methodology across all coverage
Trusted by Institutional Investors
for Over 35 Years
Years of IPO Expertise
Client Renewal Rate
IPOs Analyzed
“Their IPO research has been an integral part of our investment process for over 15 years.”
— $200B+ Asset Manager
“Renaissance has cornered the market for smart and timely pre-IPO research.”
— SMID Cap Fund Manager
Same IPO. Same Allocation Window.
Better Research.
That's the Difference.
Request your trial with full access, custom onboarding, and personal support after qualification.
Request Your TrialContact us to learn more about our IPO Intelligence Research platform